A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia
Status:
Not yet recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
A Randomized Study of ALG-055009 Drug to Evaluate the Safety, Tolerability, Pharmacokinetics
and Pharmacodynamics of Single and Multiple Doses in Healthy Volunteers and Subjects with
Hyperlipidemia